Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Catalent and Lonza's Imbruvica contracts safe says AbbVie, post $21bn acq

AbbVie has closed the acquisition of Pharmacyclics and confirms it will continue to outsource manufacture the oncology drug Imbruvica.

LabCorp outlines near-term goals following Covance integration

With the integration of Covance moving along steadily, Dave King, chairman and CEO of LabCorp, told investors last week at the UBS Healthcare Conference that LabCorp is ramping up a series of initiatives that will lead to $300m (€276m) in new revenue opportunities.

Lonza set to get commercial Adva-27a contract if cancer drug is approved

Lonza shipped a sample batch of a drug for resistant cancers this week and is set produce commercial supplies if it goes on to be approved says Sunshine Biopharma.

Merck Millipore nabs Singulex’s protein detection technology

Merck Millipore has entered an agreement whereby it will control and manage the Singulex Life Science Research business, which offers a technology that can provide ultra-sensitive protein detection. 

Ergomed bolsters post-marketing biz through acquisition

UK-based CRO Ergomed has acquired medical information firm Sound Opinion as a boost to its post-marketing services.

CROs look to buttress research models businesses with CRISPR/Cas tech

As the largest pharma and tech suppliers – from Novartis to GE Healthcare to Thermo Fisher – begin exploring the world of CRISPR/Cas gene editing technology, contract research organizations are also looking into the new tech to explore ways to help clients’ research models.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...